bpc.157 Orthopedic Use of BPC-157 NEW Biote BPC-157 + KPV

In addition, we stated in the CY 2026 OPPS/ASC proposed rule that we are concerned that the provided evidence did not directly support the applicant's 10 claims that the Axoguard HA+ Nerve Protector TM demonstrates substantial clinical improvement over existing technologies

Those chasing strength or fat-loss goals value steady energy over quick spikes

Track your own progress rather than measuring against others

Discontinuing an evidence-based IBD therapy like a biologic in favor of an unregulated peptide carries an exceptionally high risk of inducing a severe, uncontrolled disease flare that could lead to hospitalization or surgery